FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

58 letters match. Newest first.

  1. Jost Chemical Co.

    Jost Chemical Co. made active drug ingredients under CGMP deviations, including mold contamination and inadequate investigations.

    High risk
  2. The W.S. Badger Company, Inc.

    FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.

    High risk
  3. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  4. Aurobindo Pharmaceutical Limited

    FDA warned Aurobindo Pharmaceutical Limited after an inspection found manufacturing practice failures in drug ingredients and inadequate investigations.

    High risk
  5. Sunstar Americas, Inc.

    Sunstar Americas' water and quality failures led to contamination and recalls of oral rinses and dry-mouth devices.

    High risk
  6. Dental Technologies Inc.

    FDA warned Dental Technologies Inc. over contaminated Paroex oral rinse and inadequate drug and device manufacturing controls.

    High risk
  7. Missouri Analytical Laboratories Inc

    Missouri Analytical Laboratories, a contract drug testing lab, cited for manufacturing practice violations including inadequate out-of-specification investigations and data integrity failures.

    High risk
  8. Toyobo Co. Ltd.

    FDA warned Toyobo after inspection found unresolved particulate contamination and environmental monitoring data manipulation affecting sterile injectable drugs.

    High risk